Risk of diabetes mellitus in residents living in a vulnerable area of North Lima
DOI:
https://doi.org/10.56294/shp202231Keywords:
Risk, Diabetes mellitus type 2, Public health, Primary health careAbstract
Type 2 diabetes mellitus is currently one of the most prevalent diseases, and the risk of developing it is increasing. Therefore, the objective of this research is to determine the risk of diabetes mellitus in residents of a vulnerable area of northern Lima. This is a quantitative, descriptive, cross-sectional study with a total population of 140 who responded to a questionnaire on sociodemographic data and the diabetes mellitus risk test. The results show that 20.6% (n=21) have a low risk of diabetes mellitus, 24.5% (n=25) have a slightly elevated risk, 31.4% (n=32) have a moderate risk, 14.7% (n=15) have a high risk, and 8.8% (n=9) have a very high risk. In conclusion, lifestyle changes are needed to adopt healthier habits that allow for the adaptation of healthier eating behaviours that promote good health.
References
Organización Mundial de la Salud, “Diabetes,” OMS, 2022. https://www.who.int/health-topics/diabetes#tab=tab_1.
[2] E. Dal Canto et al., “Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications,” Eur. J. Prev. Cardiol., vol. 26, no. 2, pp. 25–32, 2019, doi: 10.1177/2047487319878371.
[3] B. Martínez, V. Falcón, N. Martínez, and G. Vizuete, “Estudio de Casos y Controles sobre Factores de Riesgo de Diabeltes Mellitus Tipo 2 en Adultos Mayores,” Rev. Univ. y Soc., vol. 12, no. 4, pp. 156–164, 2020, [Online]. Available: http://scielo.sld.cu/pdf/rus/v12n4/2218-3620-rus-12-04-156.pdf.
[4] U. Galicia et al., “Pathophysiology of type 2 diabetes mellitus,” Int. J. Mol. Sci., vol. 21, no. 17, p. 6275, 2020, doi: 10.3390/ijms21176275.
[5] H. Mariano, D. Ocampo, and K. Cuello, “Uso del instrumento FINDRISK para identificar el riesgo de prediabetes y diabetes mellitus tipo 2,” Rev. Repert. Med. y Cirugía, vol. 28, no. 3, pp. 157–163, 2019, doi: 10.31260/repertmedcir.v28.n3.2019.956.
[6] F. Cuevas et al., “Mal control de la diabetes tipo 2 en un centro de salud de atención primaria: factores modificables y población diana,” Aten. Primaria, vol. 53, no. 9, p. 102066, 2021, doi: 10.1016/j.aprim.2021.102066.
[7] L. Bartra, J. Ausejo, I. Córdova, J. Córdova, J. Chávez, and C. Mejia, “Diabetes Mellitus Tipo 2 Como Factor De Riesgo Para Mortalidad Por Covid-19.,” Rev. Médica Panacea, vol. 9, no. 3, pp. 189–193, 2021, doi: 10.35563/rmp.v9i3.373.
[8] E. Alustiza et al., “Tackling risk factors for type 2 diabetes in adolescents: PRE-STARt study in Euskadi,” An. Pediatr., vol. 95, no. 3, pp. 186–196, 2021, doi: 10.1016/j.anpedi.2020.11.001.
[9] B. Meneses, N. Gonzalez, W. Alvarado, and J. Meneses, “Quality of life in patients with diabetes mellitus treated in an outpatient clinic of a hospital in North Lima,” Int. J. Adv. Appl. Sci., vol. 9, no. 5, pp. 1–8, 2022, doi: 10.21833/ijaas.2022.05.001.
[10] J. Asenjo, “Riesgo de diabetes mellitus tipo 2 en usuarios de un programa de ejercicio físico,” Rev. Finlay, vol. 10, no. 4, pp. 392–398, 2020, [Online]. Available: https://revfinlay.sld.cu/index.php/finlay/article/view/866/1934.
[11] M. Heredia and E. Cabriales, “Risk of type 2 diabetes mellitus and its determinants,” Enferm. Glob., vol. 21, no. 1, pp. 179–190, 2022, doi: 10.6018/EGLOBAL.482971.
[12] M. Rodríguez and M. Mendoza, “Factores de riesgo de diabetes mellitus tipo 2 en poblacion adulta,” Rev. Colomb. Endocrinol. Diabetes y Metab., vol. 6, no. 2, pp. 86–91, 2019, [Online]. Available: https://revistaendocrino.org/index.php/rcedm/article/view/482/627.
[13] A. Palacios, M. Durán, and O. Obregón, “Factores de riesgo para el desarrollo de Diabetes tipo 2 y Síndrome Metebólico entre Profesionales de Enfermería,” Rev. Venez. Endocrinol. y Metab., vol. 10, no. 1, pp. 34–40, 2012, [Online]. Available: https://www.uv.mx/rm/num_anteriores/revmedica_vol18_num2/articulos/Factores-AO.pdf.
[14] C. Bohórquez et al., “Factores Modificables y Riesgo de Diabetes Mellitys Tipo 2 en adultos jóvenes: Estudio Trasnversal,” Cienc. y Enferm., vol. 26, no. 14, pp. 1–11, 2020, doi: 10.29393/ce26-7fmcb70007.
[15] J. Velasco, J. Cunalema, I. Basurto, M. Eguiguren, and M. Lozano, “Evaluación del riesgo de diabetes mellitus tipo 2 en pacientes afectados con tuberculosis,” Enfermería Glob., vol. 19, no. 1, pp. 151–166, 2020, doi: 10.6018/eglobal.19.1.357981.
[16] H. Utli and B. Do, “The effect of the COVID-19 pandemic on self-management in patients with type 2 diabetics,” Prim. Care Diabetes jou, vol. 1, no. 1, pp. 799–805, 2021, [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293559/pdf/main.pdf.
[17] C. Fernández and P. Baptista, “Metodología de la Investigación.” p. 634, 2015, [Online]. Available: http://observatorio.epacartagena.gov.co/wp-content/uploads/2017/08/metodologia-de-la-investigacion-sexta-edicion.compressed.pdf.
[18] Fundación para la Diabetes, “Resultados Test Findrisk 2017,” 2017. https://www.fundaciondiabetes.org/general/articulo/215/resultados-test-findrisk-2017.
[19] T. Saaristo et al., “Cross-sectional evaluation of the Finnish Diabetes Risk Score: A tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome,” Diabetes Vasc. Dis. Res., vol. 2, no. 2, pp. 67–72, 2005, doi: 10.3132/dvdr.2005.011.
Published
Issue
Section
License
Copyright (c) 2022 Jorge Arturo Zapana-Ruiz , Susan Gutiérrez-Rodríguez (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
